Needle Free Injection System Market Global Size, Demand & Forecast 2034
- Pallavi Garudkar
- Mar 10
- 3 min read
According to Fortune Business Insights the global needle free injectors market size was valued at USD 113.2 million in 2025. The market is projected to grow from USD 130.21 million in 2026 to USD 404 million by 2034, exhibiting a CAGR of 15.2% during the forecast period. The needle-free injection system market includes medical devices that deliver drugs or vaccines without the use of conventional needles. These systems use high pressure, gas propulsion, or spring mechanisms to push medication through the skin, offering a painless and safer alternative to traditional injections.
Key Market Insights
Increasing demand for painless drug delivery technologies
Rising global vaccination programs
Growing use of self-administration drug delivery devices
Expansion of home healthcare and remote patient monitoring
Get a Free Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/needle-free-injection-system-market-112405
Market Insights
What are the key insights of the Needle-Free Injection System Market?
Needle-free injection devices improve patient comfort and treatment adherence, especially among patients with needle phobia.
The growing prevalence of chronic diseases such as diabetes and cardiovascular disorders is increasing the demand for advanced drug delivery systems.
Governments and healthcare organizations are adopting needle-free systems in large-scale immunization programs to improve efficiency and safety.
Technological innovations such as micro-nozzle jet injectors and smart drug delivery devices are expanding market applications.
Market Segmentation
By Technology
Gas-Propelled Injectors
Spring-Loaded Injectors
Vibration-Enabled Injectors
Gas-propelled injectors dominate the market due to their efficiency and precision in delivering drugs through the skin without needles.
By Product Type
Liquid-Based Needle-Free Injectors
Powder-Based Needle-Free Injectors
Depot-Based Injectors
Liquid-based injectors hold the largest market share, as they are commonly used for vaccines and insulin delivery.
By Application
Vaccine Delivery
Insulin Delivery
Pain Management
Dermatology
Oncology
The vaccine delivery segment dominates the market, supported by global immunization programs and demand for safer injection methods.
By End-User
Hospitals
Clinics
Home Care Settings
Research Laboratories
Hospitals hold the largest share because they use needle-free injection systems for vaccination, chronic disease treatment, and medication administration.
Market Drivers
Rising Prevalence of Chronic Diseases: Increasing cases of diabetes and cardiovascular diseases are boosting demand for efficient and painless drug delivery systems.
Growing Vaccination Programs: Large-scale immunization campaigns require fast and safe delivery methods, increasing adoption of needle-free technologies.
Increasing Patient Preference for Painless Treatments: Needle-free systems reduce anxiety associated with injections and improve treatment compliance.
Technological Advancements: Innovations in jet injector technology and microfluidics are improving drug delivery accuracy and efficiency.
Competitive Landscape
The needle-free injection system market is technology-driven and moderately competitive, with several medical device manufacturers focusing on innovation.
Key Competitive Strategies
Development of advanced jet injector technologies
Strategic collaborations with pharmaceutical companies
Expansion of vaccination delivery solutions
Investment in research and development
Key Players in the Needle-Free Injection System Market
PharmaJet (U.S.)
CROSSJECT (France)
Portal Instruments (U.S.)
NuGen Medical Devices (Canada)
INOVIO Pharmaceuticals (U.S.)
Ferring (Switzerland)
Aijex Pharma International Inc. (Japan)
IntegriMedical (U.S.)
Key Industry Development:
March 2025: PharmaJet announced that its Tropis intradermal (ID) delivery system, a needleless injection system, was used in the World Health Organization’s (WHO) polio eradication campaign held in Pakistan in February 2025.
February 2025: PharmaJet shared the latest immunization study results at the 61st Annual Medical Conference and International Health Exhibition, which occurred between the 21st and 22nd of February.
Get Your Customization Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/needle-free-injection-system-market-112405?utm_medium=seg
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights Pvt. Ltd.
9th Floor, Icon Tower,
Baner - Mahalunge Road, Baner,
Pune-411045, Maharashtra, India.
Phone:
US: +18339092966
UK: +448085020280
APAC: +91 744 740 1245Email: sales@fortunebusinessinsights.com
Comments